About Us
Stroke
Pipeline
Partners & Investors
News & Media
Contact

About Us

Nothing to display, yet.

About Us

Company Overview
Board of Directors
Project Team
Scientific founders

November 6, 2019

ACTICOR BIOTECH RAISES €7M IN ADDITION TO ITS SERIES B FINANCING, NOW COMPLETED AT €22,3M

New financing will enable the company to expand in the US its phase II clinical trial ACTIMIS for its drug candidate glenzocimab (ACT017) in acute ischemic stroke Acquisition of 100% of AVCare, a start-up developing a stroke biomarker. Paris, November 6th, 2019 – Acticor Biotech, a clinical stage biotechnology company involved in the acute phase […]

Main navigation

About Us
Stroke
Our product
Press Releases
Media Coverage
Publications
Investors

Contact

Contact Us
Follow us on Twitter
Follow us on LinkedIn

Acticor Biotech
Bâtiment Inserm U1148
Hôpital Bichat, Secteur Claude Bernard
46 rue Henri Huchard
75877 Paris Cedex 18